PharmaCyte Biotech Inc. (PMCB)
1.69
0.05 (3.05%)
At close: Mar 13, 2025, 3:59 PM
1.59
-5.91%
After-hours: Mar 13, 2025, 05:32 PM EDT
PharmaCyte Biotech Cash Flow Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 | FY04 | FY03 | FY02 | FY01 |
| Net Income | 333.76K | -4.32M | -4.24M | -3.55M | -3.83M | -4.07M | -6.83M | -4.44M | -6.06M | -10.85M | -27.25M | -1.6M | -1.9M | -1.4M | -5.99M | -6.04M | -3.79M | -3.61M | -9.39M | -4.28M | -1.72M | -32.13K | -29.85K | -7.04M |
| Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5.7K | 24.66K | 40.69K | 114.91K | 28.83K | 6.38K | 1.35K | 488.00 | 23.26K | n/a | n/a | n/a | 26.86K |
| Stock-Based Compensation | 674.69 | 645.41K | 77.96K | 370.83K | 748.03K | 705.68K | 1.53M | 1.02M | 2.1M | 6.2M | 17.93K | 984.70 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Working Capital | 37.8K | 242.95K | -24.06K | -132.03K | 203.39K | 397.83K | -72.89K | -50.75K | -712.81K | 1.43M | -432.57K | 257.42K | 59.83K | 152.02K | 206.48K | 4.65M | -2.49M | 1.03M | -4.19M | 309.14K | 1.61K | -5.33K | 7.86K | n/a |
| Other Non-Cash Items | -2.78M | 174.02K | 34.85K | -4.87K | 473.14K | 316.54K | 309.88K | 107.5K | 491.68K | -1.65M | 26.18M | 848.81K | 1.38M | 965.94K | 3.97M | 79.41K | 5.32M | 2.23M | 12.5M | 1.1M | 1.55M | n/a | n/a | 5.83M |
| Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Change in Working Capital | 298.89K | -297.17K | 9.04K | -145.61K | 267.35K | 167.1K | -85.87K | -21.16K | -873.5K | 1.74M | -491.77K | 364.56K | 238.75K | 165.85K | 930.68K | 4.75M | -2.73M | 1.03M | -4.19M | 356.24K | -45.5K | -5.33K | 7.86K | n/a |
| Operating Cash Flow | -2.15M | -3.79M | -4.12M | -3.33M | -2.34M | -2.88M | -5.08M | -3.34M | -4.35M | -4.56M | -1.56M | -390.43K | -259.29K | -225.23K | -974.06K | -1.19M | -1.19M | -351.6K | -1.07M | -2.8M | -221.03K | -37.46K | -21.99K | -1.19M |
| Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3.5M | n/a | n/a | n/a | n/a | -5.08K | -21.05K | -696.52K | -7.24K | -70.55K | -45K | n/a | n/a | -5.08K |
| Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -51.22K | -646.75K | -874.23K | n/a | n/a | 7.59K | n/a | n/a | 831.00 | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 24.97K | -31.18K | n/a | n/a | -566 | -510.03K | n/a | n/a | n/a | -31.18K |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 74.97K | -31.18K | n/a | n/a | 166.38K | 350K | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | -5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3.51K | -646.75 | 2.5K | n/a | -24.97K | 46.19K | 11.48K | 2.52K | -1.62K | n/a | n/a | n/a | n/a | 22.59K |
| Investing Cash Flow | -5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3.55M | -646.75K | -871.73K | n/a | 74.97K | -13.67K | -9.57K | -694K | 157.78K | -230.58K | -45K | n/a | n/a | -13.67K |
| Debt Repayment | n/a | n/a | n/a | n/a | 62.85K | n/a | n/a | n/a | n/a | -143.86K | 20.06K | 74.76K | 1.07M | 117.43K | -208.82K | 39.23K | n/a | n/a | 1.1M | 2.98M | 325K | n/a | n/a | n/a |
| Common Stock Repurchased | -44.36M | -13.56M | n/a | n/a | -1 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -20.12K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 17.49M | 880.00 | -50.8K | -62.44K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 20.12K | n/a | 120.58K | n/a | n/a | n/a | 24.63K | 37.46K | 21.99K | 289.23K |
| Financial Cash Flow | -10.71M | -13.56M | 87.31M | 4.64M | 2.73M | 2.34M | 2.68M | 4.88M | 3.57M | 3.64M | 8.53M | 1.22M | 1.09M | 281.72K | 296.08K | 289.23K | 1.61M | 1.09M | 1.95M | 2.98M | 349.63K | 37.46K | 21.99K | 289.23K |
| Net Cash Flow | -17.86K | -17.36M | 83.2M | 1.31M | 379.61K | -544.54K | -2.4M | 1.54M | -778.91K | -916.73K | 3.42M | 183.58K | -41.48K | 56.48K | -603.01K | -909.81K | 404.43K | 40.16K | 1.03M | -45.26K | 349.63K | n/a | n/a | -909.81K |
| Free Cash Flow | -2.15M | -3.79M | -4.12M | -3.33M | -2.34M | -2.88M | -5.08M | -3.34M | -4.35M | -4.56M | -5.06M | -390.43K | -259.29K | -225.23K | -974.06K | -1.19M | -1.21M | -1.05M | -1.08M | -2.87M | -266.03K | -37.46K | -21.99K | -1.19M |